PRECLINICAL DEVELOPMENT OF TVAX: AN ADVANCED MULTIANTIGEN VACCINE FOR THERAPY AND PREVENTION OF MALIGNANT MESOTHELIOMA

$552,320FY2016Department of the ArmyDOD

University Of Hawaii, Honolulu

Investigators